Physician profile
Ashley D Kent
NPI 1225105026
$9,663.58
in general payments reported to CMS, 2019-2025
53 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $1,335 · 2021: $2,244 · 2022: $1,798 · 2023: $1,690 · 2024: $1,336 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,182.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $662.66 | 2021-2024 | |
| Emd Serono, INC. | $550.10 | 2019-2024 | Mavenclad |
| Neurocrine Biosciences, INC. | $446.79 | 2019-2024 | Ingrezza, Ongentys |
| Genentech USA, INC. | $436.18 | 2019-2024 | Ocrevus, Enspryng |
| Novartis Pharmaceuticals Corporation | $434.78 | 2019-2022 | |
| Sk Life Science, INC. | $424.95 | 2020-2023 | |
| Amneal Pharmaceuticals LLC | $418.45 | 2020-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Lilly USA, LLC | $368.28 | 2020-2024 | Amyvid, Emgality, Reyvow |
| Sunovion Pharmaceuticals INC. | $328.94 | 2019-2022 | |
| Harmony Biosciences LLC | $308.43 | 2020-2025 | |
| Livanova USA, INC. | $302.23 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Janssen Pharmaceuticals, INC | $299.94 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $275.90 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $263.61 | 2020-2024 | |
| Eisai INC. | $262.46 | 2021-2024 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.